SkQ1 Separates Mitochondrial Apoptosis from Atrophy

2026-09-28

This preprint uses a metastatic ovarian cancer mouse model to test whether mitochondrial reactive oxygen species, apoptosis, or necroptosis drive skeletal muscle atrophy. Chronic SkQ1 treatment reduced mitochondrial hydrogen peroxide emission and caspase activity in late-stage disease but did not preserve gastrocnemius mass, separating mitochondrial apoptotic signaling from type II B fibre loss.

UHRF1, Super-Enhancers, and Osteoporosis

2026-09-28

This study connects UHRF1-dependent DNA 5-methylcytosine, super-enhancer organization, and TGM2-regulated autophagic flux to impaired mesenchymal stem-cell osteogenesis in senile osteoporosis. Its multi-omics and functional strategy suggests a mechanism-linked route for investigating age-related bone loss, while the reported mouse-model rescue remains preclinical.

Norepinephrine-to-Angiotensin II Conversion in Shock

2026-09-27

This post-hoc ARAMIS analysis estimated a median norepinephrine-equivalent to angiotensin II conversion ratio of 10:1 for norepinephrine bitartrate in patients with vasodilatory hypotension. The estimate offers a practical reference for critical-care research, but its small, single-center cohort and observational design do not establish a universal dosing rule.

L-Alanyl-L-Glutamine: Practical Lab Workflow

2026-09-26

L-Alanyl-L-glutamine is a water-soluble dipeptide for workflows that need a defined alanine–glutamine source and gastrointestinal model support. It is unsuitable for DMSO- or ethanol-based formulations, and aqueous solutions are not recommended for long-term storage; the dossier does not specify assay concentrations or dosing.

Chloroquine Diphosphate in AML Ferroptosis Workflows

2026-09-25

Use Chloroquine Diphosphate as a controlled autophagy and lysosomal perturbation alongside—not as proof of—ferroptosis in AML models. This workflow connects the DGLA–ACSL4 findings to practical dose-finding, orthogonal readouts, and troubleshooting for cancer research.

CNQX: AMPA/Kainate Blockade in Neuroscience

2026-09-25

CNQX, also known as 6-cyano-7-nitroquinoxaline-2,3-dione, is a competitive AMPA and kainate receptor antagonist used to dissect glutamatergic neurotransmission. A 2024 rat study found that CNQX pretreatment in the paraventricular nucleus did not attenuate the measured cardiovascular responses to chemerin-9 delivered in the caudal nucleus tractus solitarius, unlike NMDA-receptor blockade.

BV6 and Cell-Death Assay Interpretation

2026-09-24

BV6 is an IAP antagonist used to investigate apoptosis and treatment sensitization in cancer models. This article connects its reported activity with a key cell-death research finding to show why orthogonal assays and pathway-specific interpretation matter.

AAPH Workflows for Protein Oxidation and Stress Assays

2026-09-24

AAPH offers a water-compatible, sustained source of peroxyl-radical stress for protein, erythrocyte, and antioxidant studies. This guide turns a hazelnut-protein finding into practical assay choices, with pilot conditions and troubleshooting clearly distinguished from published results.

Carvacrol: Cell-Cycle and TRP Redox Research

2026-09-23

Carvacrol, also known as 5-isopropyl-2-methylphenol, is a research compound with product-documented cell-cycle and apoptosis-related effects. A 2026 study identifies carvacrol as a non-electrophilic TRPA1 agonist that helps distinguish ligand responses from singlet-oxygen-driven channel modification.

BV6 and Lysosomal Context in Cancer Cell Death

2026-09-23

BV6 is an IAP antagonist used to investigate apoptosis induction in cancer cells, radiosensitization, and immune-mediated cytotoxicity. This article adds a lysoptosis-informed framework for distinguishing apoptotic signaling from lysosomal membrane permeabilization in advanced cell-death assays.

Dabigatran Etexilate: Oral Direct Thrombin Inhibition

2026-09-22

Prestained Protein Marker: Triple-Color Workflow

2026-09-22

This guide explains how to use the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) as a visible size reference and qualitative transfer check in SDS-PAGE and Western blot workflows. It is appropriate for Phosbind SDS-PAGE and fluorescent membrane imaging, but it should not be treated as a quantitative protein calibrant or a substitute for an unstained standard when dye-free detection is required.

Nurr1+ Neurons and Rat Claustrum Development

2026-09-21

Fang, Wang, and Naumann mapped the developmental appearance and embryonic birth timing of Nurr1-positive neurons across the rat claustrum, endopiriform region, and lateral cortex. By combining EdU birth dating with Nurr1 in situ hybridization, the study resolves subregional neurogenetic gradients and provides a framework for interpreting claustral organization during development.

Intravitreal Metformin in CNV and Retinal Degeneration

2026-09-21

This preclinical study shows that intravitreal metformin can suppress choroidal neovascularization, reduce inflammatory-cell infiltration, and limit light-induced retinal thinning in mouse models. Its main contribution is the parallel evaluation of anti-angiogenic and neuroprotective effects, while also identifying inflammation- and angiogenesis-associated gene responses that warrant further translational study.

Deep Learning for iPSC-CM Cardiotoxicity Screening

2026-09-20

Grafton et al. developed a high-content imaging and deep-learning workflow that assigns a single cardiotoxicity score to compounds tested in human iPSC-derived cardiomyocytes. The study shows how phenotype-first analysis can identify diverse liability classes early in drug discovery and guide follow-up testing before late-stage development.